Lilly Blasts Compounders' 'Scattershot' Bid To Reverse FDA

By Bonnie Eslinger · April 18, 2025, 4:55 PM EDT

Eli Lilly urged a Texas federal judge Thursday to deny a request from pharmacies that produce copycat doses of its popular weight loss drug to have the court reverse an FDA...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

Outsourcing Facilities Association et al v. United States Food and Drug Administration et al

Case Number

Court

Texas Northern

Nature of Suit

Other Statutes: Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

October 07, 2024

Recent Articles By Bonnie

April 16, 2025
Blue Shield Of California Sued Over Google's Patient Data Use
April 11, 2025
Amgen Can't Ditch Regeneron's Bundling Antitrust Suit
April 10, 2025
Holmes Seeks Full 9th Circ. Review Of Theranos Fraud Appeal
April 02, 2025
NIH Sued By Researchers Over 'Ideological Purge' On Grants
March 31, 2025
Texas Judge Deems Lab-Test Rule Outside FDA Authority
March 19, 2025
Ohio Opioid Judge Says Texas Court Should Hear Appeal Bid
March 05, 2025
Arizona's 15-Week Abortion Ban Blocked As Unconstitutional
March 03, 2025
Full Fed. Circ. Won't Take On Teva's Orange Book Appeal
March 03, 2025
Sandoz Settles Florida's Generic Drug Price-Fixing Claims
February 26, 2025
Merck, Glenmark Trim United Healthcare's Zetia Antitrust Suit